KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Chemed (CHE) over the last 16 years, with FY2024 value amounting to -$359.2 million.

  • Chemed's Cash from Financing Activities fell 23533.56% to -$189.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$283.5 million, marking a year-over-year decrease of 7448.3%. This contributed to the annual value of -$359.2 million for FY2024, which is 34997.68% down from last year.
  • Per Chemed's latest filing, its Cash from Financing Activities stood at -$359.2 million for FY2024, which was down 34997.68% from -$79.8 million recorded in FY2023.
  • In the past 5 years, Chemed's Cash from Financing Activities ranged from a high of -$79.8 million in FY2023 and a low of -$380.6 million during FY2021
  • Its 5-year average for Cash from Financing Activities is -$260.0 million, with a median of -$271.2 million in 2020.
  • In the last 5 years, Chemed's Cash from Financing Activities soared by 6185.24% in 2023 and then crashed by 34997.68% in 2024.
  • Chemed's Cash from Financing Activities (Annual) stood at -$271.2 million in 2020, then tumbled by 40.34% to -$380.6 million in 2021, then soared by 45.02% to -$209.3 million in 2022, then soared by 61.85% to -$79.8 million in 2023, then crashed by 349.98% to -$359.2 million in 2024.
  • Its last three reported values are -$359.2 million in FY2024, -$79.8 million for FY2023, and -$209.3 million during FY2022.